Overview
Takafumi Miyamoto practices practicing medicine in Tsukuba, Japan.
Their clinical expertise encompasses Tangier Disease, Non-Alcoholic Fatty Liver Disease, and Hypolipoproteinemia.
They are actively involved in clinical research, co-authoring 40 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Takafumi Miyamoto
Is Takafumi Miyamoto a top-rated expert for Tangier Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Takafumi Miyamoto is classified as an Experienced expert for Tangier Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Takafumi Miyamoto participate in research or clinical trials?
Yes. Takafumi Miyamoto has published 40 articles and abstracts on conditions like Tangier Disease. You can view a list of Takafumi Miyamoto's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- HypolipoproteinemiaMiyamoto isExperienced. Learn about Hypolipoproteinemia.
- Non-Alcoholic Fatty Liver DiseaseMiyamoto isExperienced. Learn about Non-Alcoholic Fatty Liver Disease.
- Tangier DiseaseMiyamoto isExperienced. Learn about Tangier Disease.